Retrospective Brazilian Study of Fulvestrant in Advanced Breast Cancer
Study identifier:NIS-OBR-FAS-2007/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Retrospective Brazilian Study of Fulvestrant in Advanced Breast Cancer
Medical condition
Breast Cancer
Phase
-
Healthy volunteers
No
Study drug
Fulvestrant
Sex
Female
Actual Enrollment
200
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 May 2008
Primary Completion Date: 01 Apr 2009
Study Completion Date: 01 Apr 2009
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
Dendrix - Scientific Information Architecture
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 Postmenopausal women with hormone-receptor positive, advanced breast cancer who have failed at least one previous endocrine therapy and who have been treated at any one of the participating centres with fulvestrant. | - |
